Press releases
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
- Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
Key statistics
On Friday, Sarepta Therapeutics Inc (AB3A:DEU) closed at 115.00, -17.12% below its 52-week high of 138.75, set on Feb 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 107.45 |
---|---|
High | 115.00 |
Low | 107.45 |
Bid | 113.90 |
Offer | 114.40 |
Previous close | 107.55 |
Average volume | 177.00 |
---|---|
Shares outstanding | 94.52m |
Free float | 89.83m |
P/E (TTM) | 1,502.70 |
Market cap | 11.32bn USD |
EPS (TTM) | 0.0797 USD |
Data delayed at least 15 minutes, as of Jun 07 2024.
More ▼